Today announced its financial results for the three months ended June 30, 2025. Q2 Revenue was $11.8 Million, an Increase of 14% over Q2 2024. Cash balance was $10.4 Million at the end of Q2, Increased from $8.4 Million in Q1 2025. MediPharm Labs Corp. shares T.LABS are trading down $0.02 at $0.08.
Stocks in play: MediPharm Labs Corp.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here